Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma.
Pilette C, Canonica GW, Chaudhuri R, Chupp G, Lee FE, Lee JK, Almonacid C, Welte T, Alfonso-Cristancho R, Jakes RW, Maxwell A, Price RG, Howarth P. Pilette C, et al. Among authors: almonacid c. J Allergy Clin Immunol Pract. 2022 Oct;10(10):2646-2656. doi: 10.1016/j.jaip.2022.05.042. Epub 2022 Jun 24. J Allergy Clin Immunol Pract. 2022. PMID: 35753668 Free article.
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators. Harrison TW, et al. Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22. Lancet Respir Med. 2021. PMID: 33357499 Clinical Trial.
Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score.
Pérez de Llano L, Dávila I, Martínez-Moragón E, Domínguez-Ortega J, Almonacid C, Colás C, García-Rivero JL, Carmona L, García de Yébenes MJ, Cosío BG; FEOS Study Group. Pérez de Llano L, et al. Among authors: almonacid c. J Allergy Clin Immunol Pract. 2021 Jul;9(7):2725-2731. doi: 10.1016/j.jaip.2021.01.033. Epub 2021 Feb 4. J Allergy Clin Immunol Pract. 2021. PMID: 33549843
Impact of Blood Eosinophil Variability in Asthma: A Real-Life Population Study.
Toledo-Pons N, van Boven JFM, Muncunill J, Millán A, Román-Rodríguez M, López-Andrade B, Almonacid C, Álvarez DV, Kocks JWH, Cosío BG. Toledo-Pons N, et al. Among authors: almonacid c. Ann Am Thorac Soc. 2022 Mar;19(3):407-414. doi: 10.1513/AnnalsATS.202103-409OC. Ann Am Thorac Soc. 2022. PMID: 34534050
Systemic Corticosteroids in Patients with Bronchial Asthma: A Real-Life Study.
Izquierdo JL, Almonacid C, Campos C, Morena D, Benavent M, González-de-Olano D, Rodríguez JM. Izquierdo JL, et al. Among authors: almonacid c. J Investig Allergol Clin Immunol. 2021 Nov 11:0. doi: 10.18176/jiaci.0765. Online ahead of print. J Investig Allergol Clin Immunol. 2021. PMID: 34779775 Free article.
The impact of COVID-19 on patients with asthma.
Izquierdo JL, Almonacid C, González Y, Del Rio-Bermudez C, Ancochea J, Cárdenas R, Lumbreras S, Soriano JB. Izquierdo JL, et al. Among authors: almonacid c. Eur Respir J. 2021 Mar 4;57(3):2003142. doi: 10.1183/13993003.03142-2020. Print 2021 Mar. Eur Respir J. 2021. PMID: 33154029 Free PMC article.
High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study.
Monreal E, Sainz de la Maza S, Natera-Villalba E, Beltrán-Corbellini Á, Rodríguez-Jorge F, Fernández-Velasco JI, Walo-Delgado P, Muriel A, Zamora J, Alonso-Canovas A, Fortún J, Manzano L, Montero-Errasquín B, Costa-Frossard L, Masjuan J, Villar LM; COVID-HRC group. Monreal E, et al. Eur J Clin Microbiol Infect Dis. 2021 Apr;40(4):761-769. doi: 10.1007/s10096-020-04078-1. Epub 2020 Oct 20. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33083917 Free PMC article.
Knowledge of their own allergic sensitizations in asthmatic patients and its impact on the level of asthma control.
Roger A, Vázquez R, Almonacid C, Padilla A, Serrano J, García-Salmones M, Molina F, Pinedo C, Torrejón M, Picado C, López-Viña A, Plaza V; Grupo Emergente Asma. Área Asma de SEPAR. Roger A, et al. Among authors: almonacid c. Arch Bronconeumol. 2013 Jul;49(7):289-96. doi: 10.1016/j.arbres.2013.02.004. Epub 2013 Apr 6. Arch Bronconeumol. 2013. PMID: 23566766 English, Spanish.
A Proposed Approach to Chronic Airway Disease (CAD) Using Therapeutic Goals and Treatable Traits: A Look to the Future.
Pérez de Llano L, Miravitlles M, Golpe R, Alvarez-Gutiérrez FJ, Cisneros C, Almonacid C, Martinez-Moragon E, Gonzalez-Barcala FJ, Ramos-Barbón D, Plaza V, Lopez-Campos JL, de-Torres JP, Casanova C, Garcia Rivero JL, Rodriguez Hermosa J, Calle Rubio M, Soler-Cataluña JJ, Cosio BG. Pérez de Llano L, et al. Among authors: almonacid c. Int J Chron Obstruct Pulmon Dis. 2020 Sep 4;15:2091-2100. doi: 10.2147/COPD.S263430. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32943862 Free PMC article.
30 results